The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Active surveillance in patients with extra-abdominal desmoid-type fibromatosis: A combined analysis of three prospective observational studies.
 
Chiara Colombo
No Relationships to Disclose
 
Stefanie Hakkesteegt
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Bayer Health; Deciphera; PharmaMar
 
Francesco Barretta
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Dirk J. Grunhagen
No Relationships to Disclose
 
Nicolas Penel
No Relationships to Disclose
 
Laurent Lam
No Relationships to Disclose
 
Marco Fiore
No Relationships to Disclose
 
Elena Palassini
No Relationships to Disclose
 
Giovanni Grignani
No Relationships to Disclose
 
Francesco Tolomeo
No Relationships to Disclose
 
Paola Collini
No Relationships to Disclose
 
Alessandra Merlini
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Silvia Stacchiotti
Honoraria - Boehringer Ingelheim; Gentili; PharmaMar
Consulting or Advisory Role - Agenus; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Ikena Oncology; NEC OncoImmunity AS; Pharmaessentia; Regeneron; SERVIER
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Rain Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Cornelis Verhoef
No Relationships to Disclose
 
Sylvie Bonvalot
No Relationships to Disclose
 
Alessandro Gronchi
Honoraria - Deciphera; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar; SpringWorks Therapeutics
Research Funding - Nanobiotix (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar